HMOX1 is a key factor that regulates atRAL-induced ferroptosis in photoreceptors via KEAP1/NFE2L2/HMOX1 axis, and its inhibition may be a novel therapeutic strategy for the treatment of dry AMD and SD (Chen et al., 2023). This evidence concerns the gene HMOX1 and dry age related macular degeneration.